Your browser doesn't support javascript.
loading
Selection of metastasis competent subclones in the tumour interior.
Zhao, Yue; Fu, Xiao; Lopez, Jose I; Rowan, Andrew; Au, Lewis; Fendler, Annika; Hazell, Steve; Xu, Hang; Horswell, Stuart; Shepherd, Scott T C; Spain, Lavinia; Byrne, Fiona; Stamp, Gordon; O'Brien, Tim; Nicol, David; Augustine, Marcellus; Chandra, Ashish; Rudman, Sarah; Toncheva, Antonia; Pickering, Lisa; Sahai, Erik; Larkin, James; Bates, Paul A; Swanton, Charles; Turajlic, Samra; Litchfield, Kevin.
Afiliação
  • Zhao Y; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Fu X; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Lopez JI; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Rowan A; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Au L; Biomolecular Modelling Laboratory, The Francis Crick Institute, London, UK.
  • Fendler A; Department of Pathology, Cruces University Hospital, Biocruces-Bizkaia Institute, Barakaldo, Spain.
  • Hazell S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Xu H; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Horswell S; Renal and Skin Unit, the Royal Marsden NHS Foundation Trust, London, UK.
  • Shepherd STC; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Spain L; Department of Pathology, The Royal Marsden NHS Foundation Trust, London, UK.
  • Byrne F; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Stamp G; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
  • O'Brien T; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Nicol D; Renal and Skin Unit, the Royal Marsden NHS Foundation Trust, London, UK.
  • Augustine M; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Chandra A; Renal and Skin Unit, the Royal Marsden NHS Foundation Trust, London, UK.
  • Rudman S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Toncheva A; Experimental Histopathology Laboratory, The Francis Crick Institute, London, UK.
  • Pickering L; Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Sahai E; Department of Urology, The Royal Marsden NHS Foundation Trust, London, UK.
  • Larkin J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Bates PA; Department of Pathology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Swanton C; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Turajlic S; Biobank, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Litchfield K; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.
Nat Ecol Evol ; 5(7): 1033-1045, 2021 07.
Article em En | MEDLINE | ID: mdl-34002049
ABSTRACT
The genetic evolutionary features of solid tumour growth are becoming increasingly well described, but the spatial and physical nature of subclonal growth remains unclear. Here, we utilize 102 macroscopic whole-tumour images from clear cell renal cell carcinoma patients, with matched genetic and phenotypic data from 756 biopsies. Utilizing a digital image processing pipeline, a renal pathologist marked the boundaries between tumour and normal tissue and extracted positions of boundary line and biopsy regions to X and Y coordinates. We then integrated coordinates with genomic data to map exact spatial subclone locations, revealing how genetically distinct subclones grow and evolve spatially. We observed a phenotype of advanced and more aggressive subclonal growth in the tumour centre, characterized by an elevated burden of somatic copy number alterations and higher necrosis, proliferation rate and Fuhrman grade. Moreover, we found that metastasizing subclones preferentially originate from the tumour centre. Collectively, these observations suggest a model of accelerated evolution in the tumour interior, with harsh hypoxic environmental conditions leading to a greater opportunity for driver somatic copy number alterations to arise and expand due to selective advantage. Tumour subclone growth is predominantly spatially contiguous in nature. We found only two cases of subclone dispersal, one of which was associated with metastasis. The largest subclones spatially were dominated by driver somatic copy number alterations, suggesting that a large selective advantage can be conferred to subclones upon acquisition of these alterations. In conclusion, spatial dynamics is strongly associated with genomic alterations and plays an important role in tumour evolution.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variações do Número de Cópias de DNA / Neoplasias Limite: Humans Idioma: En Revista: Nat Ecol Evol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variações do Número de Cópias de DNA / Neoplasias Limite: Humans Idioma: En Revista: Nat Ecol Evol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido